Title | Organ Transplant |
---|---|
Author | Andreas Espehana |
Course | Medicine |
Institution | King's College London |
Pages | 4 |
File Size | 112.8 KB |
File Type | |
Total Downloads | 87 |
Total Views | 145 |
notes on organ transplantation...
Organ Transplant Organ transplantation: immunosuppressants A number of drugs are available which help to mitigate the processes resulting in acute rejection. Cyclosporin and tacrolimus are commonly used drugs. Example regime Initial: ciclosporin/tacrolimus with a monoclonal antibody Maintenance: ciclosporin/tacrolimus with MMF or sirolimus Add steroids if more than one steroid responsive acute rejection episode Ciclosporin Inhibits calcineurin, a phosphatase involved in T cell activation Nephrotoxic Monitor levels Azathioprine Metabolised to form 6 mercaptopurine which inhibits DNA synthesis and cell division Side effects include myelosupression, alopecia and nausea Tacrolimus Lower incidence of acute rejection compared to ciclosporin Also less hypertension and hyperlipidaemia However, high incidence of impaired glucose tolerance and diabetes metabolised via P450 system Mycophenolate mofetil (MMF) Blocks purine synthesis by inhibition of IMPDH Therefore inhibits proliferation of B and T cells
Side-effects: GI and marrow suppression Sirolimus (rapamycin) Blocks T cell proliferation by blocking the IL-2 receptor Can cause hyperlipidaemia Monoclonal antibodies Selective inhibitors of IL-2 receptor Daclizumab Basilximab
Complications The kidney is highly susceptible to HLA mismatches and hyperacute rejection may occur in patients with IgG anti HLA DR Class I antibodies. The liver is at far lower risk of rejection of this nature. Although the heart is sensitive to HLA mismatches this is less than the kidney. Cardiac valves and the cornea incite little immunological response. Post transplant complications - CMV: 4 weeks to 6 months post transplant - EBV: post transplant lymphoproliferative disease. > 6 months post transplant
Complications following renal transplant Renal transplantation is widely practised. The commonest technical related complications are related to the ureteric anastomosis. The warm ischaemic time is also of considerable importance and graft survival is directly related to this. Long warm ischaemic times increase the risk of acute tubular necrosis which may occur in all types of renal transplanation and provided other insults are minimised, will usually recover. Organ rejection may occur at any phase following the transplantation process. Immunological complications Types of organ rejection
Hyperacute. This occurs immediately through presence of pre formed antibody (such as ABO incompatibility). Acute. Occurs during the first 6 months and is usually T cell mediated. Usually tissue infiltrates and vascular lesions. Chronic. Occurs after the first 6 months. Vascular changes predominate. Hyperacute Renal transplants are most susceptible to this process. Risk factors include major HLA mismatch and ABO incompatibility. The rejection occurs almost immediately and the macroscopic features may become manifest following completion of the vascular anastomosis and removal of clamps. The kidney becomes mottled, dusky and the vessels will thrombose. The only treatment is removal of the graft, if left in situ it will result in abscess formation. Hyperacute graft rejection is due to pre-existent antibodies to HLA antigens and is therefore IgG mediated Acute (6 months) Again all transplants with HLA mismatch may suffer this fate. Previous acute rejections and other immunosensitising events all increase the risk. Vascular changes are most prominent with myointimal proliferation leading to organ ischaemia. Organ specific changes are also seen such as loss of acinar cells in pancreas transplants and rapidly progressive coronary artery disease in cardiac transplants. causes Chronic allograft nephropathy Ureteric obstruction
Recurrence of original renal disease (MCGN > IgA > FSGS)
Technical Complications
Immediate surgery may Renal artery thrombosis
salvage the graft, delays Sudden complete loss of urine output
beyond 30 minutes are associated with a high rate of graft loss
Renal artery
Uncontrolled hypertension, allograft
Angioplasty is the treatment
stenosis
dysfunction and oedema
of choice
Renal vein
Pain and swelling over the graft site, haematuria
thrombosis
and oliguria
Urine leaks
Diminished urine output, rising creatinine, fever and abdominal pain
The graft is usually lost USS shows perigraft collection, necrosis of ureter tip is the commonest cause and the anastomosis may need revision
Lymphocele
Common complication (occurs in 15%), may present as a mass, if large may compress ureter.
May be drained with percutaneous technique and
May present as swelling of graft but with normal
sclerotherapy, or
function. Limb swelling may be present
intraperitoneal drainage...